Journal article
Current Incidence and Outcomes of Gastrointestinal Mesenchymal Tumors Including Gastrointestinal Stromal Tumors
Abstract
BACKGROUND: Gastrointestinal stromal tumors (GISTs) have been recognized as the most common mesenchymal tumors of the gastrointestinal tract. The most effective treatment for unresectable tumors is imatinib mesylate, based on two phase II trials. Because no phase III clinical trial has been undertaken, we sought to determine both current population-based incidence and whether improved outcomes noted in both individual centers and clinical …
Authors
Perez EA; Livingstone AS; Franceschi D; Rocha-Lima C; Lee DJ; Hodgson N; Jorda M; Koniaris LG
Journal
Journal of the American College of Surgeons, Vol. 202, No. 4, pp. 623–629
Publisher
Wolters Kluwer
Publication Date
4 2006
DOI
10.1016/j.jamcollsurg.2006.01.002
ISSN
1072-7515